Research Paper Volume 12, Issue 11 pp 10663—10675
Association between immune-related adverse events and efficacy of PD-1 inhibitors in Chinese patients with advanced melanoma
Figure 1. Kaplan-Meier analysis of survival among patients who experienced an immune-related adverse events (irAEs) or not. Shown are the curves for (A) progression-free survival (PFS) and (B) overall survival (OS) in patients with irAEs or not. A statistically significant OS and PFS difference were noted among those experiencing any irAEs versus those who did not (P < 0.05).